This is the Podcast of the Europen Society for Molecular Imaging (ESMI).
Pour yourself a nice glass of wine and join us as we delve into the recent literature, and perhaps learn a little from the minds that have shaped the field.
The premise is really simple: Each time we invite one senior academic to discuss their favourite publication from the recent literature. We’ll find out what caught their eye, and why it is worth taking a closer look at this particular publication. Along the way, we will learn their publication strategies and possibly even glimpse into the future of this amazing field of research.
Music “In this Life”, Composer: Guido Jäger, Musicians: Andreas Jacobs – violin, Jacob Niller – accordion, Wolfgang Platen – contrabass
Giannis is a Principal Researcher at the Institute of Electronic Structure and Laser – Foundation for Research and Technology (FORTH – IESL) in Heraklion, Crete and the Head of the Laboratory for Biophotonics and Molecular Imaging. Giannis had been elected as ESMI Vice President in 2018 and served as President from 2019 to 2020.
Tim is a Wellcome Trust Senior Research Fellow and Senior Lecturer at King’s College London’s School of Biomedical Engineering & Imaging Sciences. His Group’s research focuses on the development of next-generation imaging tools for cancer diagnosis, monitoring of therapeutic response, and detection of drug resistance. Tim has been serving as member of the ESMI Board since 2018.
John is the Director of the Imaging Laboratories at the Robarts Research Institute, Director of the Translational Immune-Oncology Research Group at the Centre for Translational Cancer Research, and an Associate Professor in Medical Biophysics at The University of Western Ontario in Canada.
He completed his PhD at Western before moving to Stanford University in the lab of Sam Gambhir on a postdoctoral fellowship. After an incredibly successful postdoc in California, working with some amazing scientists, I might add, he returned to Western in 2015 to set up his group. Here, they combine advances in molecular and synthetic biology with a multimodal imaging perspective to build new tools for early detection and treatment of cancer, as well as non-invasive monitoring of cell, gene and genome therapies.